---
title: "SOJO: Net profit in the first half of 2025 increased by 20.11% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254470185.md"
description: "SOJO announced that in the first half of 2025, operating revenue reached 2.376 billion yuan, a year-on-year increase of 41.95%. Net profit was 104 million yuan, a year-on-year increase of 20.11%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital"
datetime: "2025-08-25T14:21:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254470185.md)
  - [en](https://longbridge.com/en/news/254470185.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254470185.md)
generator: "portal-rs"
---

# SOJO: Net profit in the first half of 2025 increased by 20.11% year-on-year

SOJO announced that its operating revenue in the first half of 2025 was 2.376 billion yuan, a year-on-year increase of 41.95%. The net profit was 104 million yuan, a year-on-year increase of 20.11%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital

### Related Stocks

- [300444.CN](https://longbridge.com/en/quote/300444.CN.md)

## Related News & Research

- [Dajin Heavy Industry Releases Unaudited Interim Results for First Half of 2026](https://longbridge.com/en/news/296656593.md)
- [Dajin Heavy Industry calls extraordinary general meeting](https://longbridge.com/en/news/296615574.md)
- [Celesc board signs off on Q2 2026 interim financial statements](https://longbridge.com/en/news/296404844.md)
- [Innventure directors force management, board to forfeit Accelsius earnout shares tied to DarkNX order](https://longbridge.com/en/news/296352522.md)
- [Tvardi Therapeutics: TTI-109 targets STAT3 to address unmet needs in UC with selective immune modulation and safety](https://longbridge.com/en/news/296374826.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**